Amorepacific Group has developed a chipless wireless electronic skin that accurately analyzes and measures skin conditions in collaboration with professor Kim Jeehwan of the Massachusetts Institute of Technology (MIT).
The technology, developed after four years of joint research, does away with the use of heavy equipment.
The scholarly publication Science reported the results of this breakthrough.
By making it simpler to identify the skin ailments of people who work in specialized surroundings while being exposed to cold, heat, or dryness, Amorepacific anticipates that this technology will aid in the development of customized functional cosmetics.
Major brands like Sulwhasoo from Amorepacific will leverage the technology developed from this study.
Clinical skin research demands the use of expensive diagnostic tools in addition to sustaining a constant temperature and humidity level.
As a result, there aren't many results from skin research that were obtained in unique circumstances.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Why financial hardship is more likely if you’re disabled or sick
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Can your cat recognise you by scent? New study shows it’s likely
Instagram Outage Disrupts Thousands of U.S. Users
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Why a ‘rip-off’ degree might be worth the money after all – research study
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



